Well, Well, Well... Greiner's 1536 Micro Assay Plates

The introduction of the 384-well plate in 1994 marked a milestone in the biotechnology and high throughput screening arenas. Likewise, 1997 will be considered a milestone year with the debut of the 1536-well plate. Greiner America (Lake Mary, Fla.) introduced the 1536 Micro Assay Plates last year. The continuing struggle of reducing cost per assay has led to the concurrent explosion in development of high-density products, including microplates. This new plate from Greiner can reportedly save u

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The introduction of the 384-well plate in 1994 marked a milestone in the biotechnology and high throughput screening arenas. Likewise, 1997 will be considered a milestone year with the debut of the 1536-well plate. Greiner America (Lake Mary, Fla.) introduced the 1536 Micro Assay Plates last year. The continuing struggle of reducing cost per assay has led to the concurrent explosion in development of high-density products, including microplates. This new plate from Greiner can reportedly save up to 60 times the amount of reagents and materials compared to conventional plates.

1536 Micro Assay Plates from Greiner America Equivalent to sixteen 96-well microplates, each well has a volume of 12µl with a working volume of 2µl to 10µl. The 1536-well plate also has an area-to-volume ratio that is three times higher than a 384-well plate. Unlike it's 384-well sister, though, the 1536 Micro Assay Plate features an optional robotics-friendly low-profile lid ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies